Obama's big cancer initiative "is already off course" because its steering committee lacks representation from key subspecialties, writes a radiation oncologist on KevinMD.
Detergent makers have a plan to keep kids from eating those candy-colored, fruit-scented little packets: make them less tasty.
Multiple sclerosis researchers may be interested in a new database containing records of some 2,500 placebo-group patients in MS drug trials, developed by the National MS Society and the Critical Path Institute.
Britain's "junior doctors" are striking again, this time walking out of all NHS units including emergency departments and intensive care. (Reuters)
The Washington Post gets a look at items from the defunct Museum of Menstruation, including the "sanitary apron" and a 1920s ad for Lysol as a douche.
Cabozantinib (Cabometyx) is now FDA-approved as second-line therapy for advanced renal cancer, its manufacturer said.
A technology to connect healthcare providers with medical scribes via Google Glass now has some $40 million behind it. (Reuters)
Médecins Sans Frontières (Doctors Without Borders) wants a more focused approach to malaria and wants it now. (PLOS Blogs)
AbbVie said its Viekira Pak hepatitis C treatment won an indication expansion from the FDA, to include its use as monotherapy in HCV genotype 1b.
AstraZeneca will sell its recently approved gout drug lesinurad (Zurampic) to Ironwood Pharmaceuticals for some $265 million. (Reuters)
Sports drink or plain water after exercise? LiveScience weighs them up.
What do you think about this ECG? (Dr. Smith's ECG Blog)
Hilda Bastian, PhD, warns that the mighty P-value is an unclothed emperor.
Rivaroxaban (Xarelto) won't have to face generic competition until at least 2024, thanks to a U.S. patent extension, said manufacturer Bayer.
Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.
Morning Break: Moonshot Criticized; British Docs Walk Out; MSF on Malaria
Aucun commentaire:
Enregistrer un commentaire